As the world’s largest next-generation sequencing application company, the world’s largest Oxford Nanopore sequencing center and the first third-generation sequencing precision medical company, Grandomics provides sophisticated genomic analysis solutions that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. At present, Grandomics has fully launched the third-generation sequencing services in the field of genetic diseases, tumors and human microbiome , including whole genome sequencing, full-length transcriptome sequencing, whole genome methylation sequencing and so on, which offer the most comprehensive view of genomes, transcriptomes, and epigenomes — including the full spectrum of genetic variations. We believe that our services will lead to advances that will create long-lasting benefits for clinical medicine and human health.

GrandOmics (希望组)

GrandOmics (希望组)